Stay updated on Venetoclax with Azacitidine post-SCT in AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax with Azacitidine post-SCT in AML Clinical Trial page.

Latest updates to the Venetoclax with Azacitidine post-SCT in AML Clinical Trial page
- Check4 days agoChange DetectedA new 2026-06-04 history entry shows Results Posted with Adverse Events and Study Status, updating the record to Revision: v3.5.5; the prior 2025-10-06 entry for Results Submitted (Revision: v3.5.4) was removed from the history.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedNew navigation items and sections were added to the study record page, including Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, and more, expanding how the record content is organized. A new 'Returned: 2026-05-19' timestamp was added.SummaryDifference0.5%

- Check26 days agoChange DetectedThe page footer now displays Revision: v3.5.4, reflecting a minor platform update to the history page. This change does not modify study data or how users interact with the page.SummaryDifference0.0%

- Check40 days agoChange DetectedThe history now shows a 'Results Submitted' entry, indicating that results have been submitted. The page revision has been updated to v3.5.3, replacing the previous v3.5.2 revision.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision history updated: added v3.5.2 and removed v3.5.0.SummaryDifference0.0%

- Check83 days agoChange DetectedAdded Revision: v3.5.0 and deleted Revision: v3.4.3 from the history.SummaryDifference0.0%

Stay in the know with updates to Venetoclax with Azacitidine post-SCT in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax with Azacitidine post-SCT in AML Clinical Trial page.